Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.
Also called NCT03004612
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 144 participants
- Sponsor
- Universidad de Guanajuato
- Registry
-
NCT03004612
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Mexico
- Registry status
- Completed
Technical summary
Registry record NCT03004612. Randomized; quadruple masking; primary purpose prevention. Start 2016-01 (registry gives no type); primary completion 2019-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes
- Acronym
- PRELLIM
- Condition
- Prediabetic State
- Condition
- Insulin Resistance
- Intervention (Combination product)
- Linagliptin + metformin
- Intervention (Drug)
- Metformin
- Lead sponsor
- Universidad de Guanajuato
- Collaborator
- Hospital Regional de Alta Especialidad del Bajio
Record details
- Record id
cardio:ct-nct03004612- Content hash
b98322622445c87ec0faa524a8403686afd113a95ead1226a4e3d4ea3ae74c2f